Ionizable lipid nanoparticles for in utero mRNA delivery is a research paper published in Science Advances (2021). On theSindex it has a DataRank of 0. It has been cited 223 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: DP2 TR002776
National Institutes of Health
Grant: DP2HL152427
National Institutes of Health
Grant: T32HL007954
National Institutes of Health
Grant: F32HL143861
National Institutes of Health
Grant: 1F32CA243475-01A1
Advancing mRNA Vaccines for Cancer Therapy Using Molecularly Barcoded Nanotechnology
National Institutes of Health
Grant: 1R01DK123049-01
In utero gene editing to cure a metabolic liver disease
Burroughs Wellcome Fund
Grant: Career Award at the Scientific Interface
NCI NIH HHS
Grant: F32 CA243475
NCI NIH HHS
Grant: R01 CA024347
NHLBI NIH HHS
Grant: R01 HL151352
NIDDK NIH HHS
Grant: R01 DK123049
National Institutes of Health
Grant: 1DP2TR002776-01
A data-driven drug delivery (4D) platform for probing and treating the chemoresistant bone marrow microenvironment
National Institutes of Health
Grant: 5T32HL007954-10
Multidisciplinary training in cardiovascular biology
National Institutes of Health
Grant: 1F32GM013039-01
MOLECULAR ANALYSIS OF THE YEAST HEAT SHOCK TRANSCRIPTION
National Institutes of Health
Grant: 1F32HL143861-01
Exosome-mediated enhancement of in utero hematopoietic stem cell transplantation for the treatment of hemoglobinopathies
National Institutes of Health
Grant: 7R01CA024347-25
HORMONAL CONTROL OF PROLIFERATION
National Institutes of Health
Grant: 1DP2HL152427-01
In utero CRISPR-mediated gene editing to cure congenital monogenic disorders
Institute for Translational Medicine and Therapeutics (ITMAT) Transdisciplinary Program in Translational Medicine and Therapeutics
Tau Beta Pi
Institute for Translational Medicine and Therapeutics (ITMAT) Transdisciplinary Program in Translational Medicine and Therapeutics.
FWCI
11.32
Citation Percentile
1.0%
Influential Citations
7
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals